RankingsPricing
  1. US-listed companies
  2. Akebia Therapeutics, Inc.
  3. Raw

Akebia Therapeutics, Inc.AKBA

Market cap
$435.98M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash and cash equivalents335018770105147229150904352
Inventories----1141166138221616
Accounts receivable, net0--3417392751393934
Prepaid expenses and other current assets23261671533342011
Total current assets110141296358468310371272185118114
Property and equipment, net209,92813481097542
Operating right-of-use assets-----29273429128
Intangible asset, net---------36-
Goodwill----55555555555959
Other long-term assets011213776385051237
Total assets111143300364997771644526352242221
Accounts payable222743394134181515
Accrued Liabilities, Current5103052151129131104716863
Current portion of long-term debt-------983218-
Working Capital Fund liability, current portion----------2
Total current liabilities71211414426620818725612510081
Long-term deferred revenue----563325214343-
Long-term operating lease liabilities-----2825342994
Long-term debt, net-----7696-341739
Liability related to settlement royalties, net of current portion----------47
Contractual Arrangement, Royalties Agreement, Liability, Noncurrent-------53575452
Contract with Customer, Refund Liability, Noncurrent---------4038
Warrant liability----------5
Other long-term liabilities0000303061831295
Total liabilities712232245361376397449342272270
Common Stock, Value, Issued----0000000
Additional paid-in capital2052933654941,1511,1891,4251,5371,5621,5781,629
Accumulated other comprehensive income-56,358-0-0-0-0-00000
Accumulated deficit-101-161-297-374-514-794-1,178-1,460-1,553-1,609-1,678
Total stockholders' deficit10413168119636395248769-31-49
Total liabilities and stockholders' deficit111143300364997771644526352242221